These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25506936)

  • 1. The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse.
    Morgan AP; Crowley JJ; Nonneman RJ; Quackenbush CR; Miller CN; Ryan AK; Bogue MA; Paredes SH; Yourstone S; Carroll IM; Kawula TH; Bower MA; Sartor RB; Sullivan PF
    PLoS One; 2014; 9(12):e115225. PubMed ID: 25506936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis.
    Abolghasemi A; Manca C; Iannotti FA; Shen M; Leblanc N; Lacroix S; Martin C; Flamand N; Di Marzo V; Silvestri C
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat.
    Davey KJ; Cotter PD; O'Sullivan O; Crispie F; Dinan TG; Cryan JF; O'Mahony SM
    Transl Psychiatry; 2013 Oct; 3(10):e309. PubMed ID: 24084940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure.
    Bahr SM; Weidemann BJ; Castro AN; Walsh JW; deLeon O; Burnett CM; Pearson NA; Murry DJ; Grobe JL; Kirby JR
    EBioMedicine; 2015 Nov; 2(11):1725-34. PubMed ID: 26870798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome.
    Skonieczna-Żydecka K; Łoniewski I; Misera A; Stachowska E; Maciejewska D; Marlicz W; Galling B
    Psychopharmacology (Berl); 2019 May; 236(5):1491-1512. PubMed ID: 30460516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain.
    Kanji S; Fonseka TM; Marshe VS; Sriretnakumar V; Hahn MK; Müller DJ
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):3-15. PubMed ID: 28624847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota.
    Kao AC; Spitzer S; Anthony DC; Lennox B; Burnet PWJ
    Transl Psychiatry; 2018 Mar; 8(1):66. PubMed ID: 29540664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
    Snigdha S; Thumbi C; Reynolds GP; Neill JC
    J Psychopharmacol; 2008 Jul; 22(5):567-71. PubMed ID: 18208914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.
    Lord CC; Wyler SC; Wan R; Castorena CM; Ahmed N; Mathew D; Lee S; Liu C; Elmquist JK
    J Clin Invest; 2017 Sep; 127(9):3402-3406. PubMed ID: 28805659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain.
    Qian L; He X; Liu Y; Gao F; Lu W; Fan Y; Gao Y; Wang W; Zhu F; Wang Y; Ma X
    Microbiol Spectr; 2023 Aug; 11(4):e0005823. PubMed ID: 37260381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
    Lian J; Huang XF; Pai N; Deng C
    Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient Cohorts.
    Gorbovskaya I; Kanji S; Liu JCW; MacKenzie NE; Agarwal SM; Marshe VS; Sriretnakumar V; Verdu EF; Bercik P; De Palma G; Hahn MK; Müller DJ
    Neuropsychobiology; 2020; 79(1):5-12. PubMed ID: 30928978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
    Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
    J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
    Deng C; Lian J; Pai N; Huang XF
    J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Olanzapine--high potency antipsychotic drug inducing significant weight gain: a case report].
    Marić N; Josifović-Kostić D; Vuković O; Britivić D; Jasović-Gasić M
    Srp Arh Celok Lek; 2008; 136(5-6):284-8. PubMed ID: 18792627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine induces remarkable weight gain in adolescent patients.
    Haapasalo-Pesu KM; Saarijärvi S
    Eur Child Adolesc Psychiatry; 2001 Sep; 10(3):205-8. PubMed ID: 11596822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amantadine on weight gain during olanzapine treatment.
    Floris M; Lejeune J; Deberdt W
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):181-2. PubMed ID: 11313165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.